These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25890059)

  • 1. Fractal dimension: a novel clot microstructure biomarker use in ST elevation myocardial infarction patients.
    Lawrence MJ; Sabra A; Thomas P; Obaid DR; D'Silva LA; Morris RH; Hawkins K; Brown MR; Williams PR; Davidson SJ; Chase AJ; Smith D; Evans PA
    Atherosclerosis; 2015 Jun; 240(2):402-7. PubMed ID: 25890059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changes in clot microstructure in patients with ischaemic stroke and the effects of therapeutic intervention: a prospective observational study.
    Stanford SN; Sabra A; D'Silva L; Lawrence M; Morris RH; Storton S; Brown MR; Evans V; Hawkins K; Williams PR; Davidson SJ; Wani M; Potter JF; Evans PA
    BMC Neurol; 2015 Mar; 15():35. PubMed ID: 25885595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Temperature on Clot Microstructure and Strength in Healthy Volunteers.
    Lawrence MJ; Marsden N; Mothukuri R; Morris RH; Davies G; Hawkins K; Curtis DJ; Brown MR; Williams PR; Evans PA
    Anesth Analg; 2016 Jan; 122(1):21-6. PubMed ID: 26440418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Patient Characteristics and Antiplatelet Regimes on Clot Microstructure in Patients Treated for ST Elevation Myocardial Infarction: Clot Microstructure can Evaluate Therapeutic Efficacy.
    Lawrence MJ; Obaid DR; Sabra A; Whitley J; Quarry R; Pillai S; Chase AJ; Smith D; Williams PR; Hawkins K; Morris RHK; Evans PA
    Clin Appl Thromb Hemost; 2023; 29():10760296221131563. PubMed ID: 36994631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention.
    Christopoulos C; Farag M; Sullivan K; Wellsted D; Gorog DA
    Thromb Haemost; 2017 Feb; 117(3):457-470. PubMed ID: 28004059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma fibrin clot phenotype independently affects intracoronary thrombus ultrastructure in patients with acute myocardial infarction.
    Zalewski J; Bogaert J; Sadowski M; Woznicka O; Doulaptsis K; Ntoumpanaki M; Ząbczyk M; Nessler J; Undas A
    Thromb Haemost; 2015 Jun; 113(6):1258-69. PubMed ID: 25739375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new structural biomarker that quantifies and predicts changes in clot strength and quality in a model of progressive haemodilution.
    Lawrence MJ; Kumar S; Hawkins K; Boden S; Rutt H; Mills G; Sabra A; Morris RH; Davidson SJ; Badiei N; Brown MR; Williams PR; Evans PA
    Thromb Res; 2014 Aug; 134(2):488-94. PubMed ID: 24965661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of post-procedural aPTT in patients with ST-elevation myocardial infarction treated with primary PCI.
    Kikkert WJ; van Nes SH; Lieve KV; Dangas GD; van Straalen J; Vis M; Baan J; Koch KT; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
    Thromb Haemost; 2013 May; 109(5):961-70. PubMed ID: 23446910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractal dimension (df) as a new structural biomarker of clot microstructure in different stages of lung cancer.
    Davies NA; Harrison NK; Morris RH; Noble S; Lawrence MJ; D'Silva LA; Broome L; Brown MR; Hawkins KM; Williams PR; Davidson S; Evans PA
    Thromb Haemost; 2015 Nov; 114(6):1251-9. PubMed ID: 26293709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro clot model to evaluate fibrin-thrombin effects on fractal dimension of incipient blood clot.
    Sabra A; Lawrence MJ; Curtis D; Hawkins K; Williams PR; Evans PA
    Clin Hemorheol Microcirc; 2019 Jul; -1():147-153. PubMed ID: 31381508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of thrombus aspiration and abciximab in primary percutaneous coronary intervention.
    Pyxaras SA; Mangiacapra F; Verhamme K; Di Serafino L; De Vroey F; Toth G; Perkan A; Salvi A; Bartunek J; De Bruyne B; Wijns W; Sinagra G; Barbato E
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):604-11. PubMed ID: 23359568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study.
    Guagliumi G; Capodanno D; Saia F; Musumeci G; Tarantini G; Garbo R; Tumminello G; Sirbu V; Coccato M; Fineschi M; Trani C; De Benedictis M; Limbruno U; De Luca L; Niccoli G; Bezerra H; Ladich E; Costa M; Biondi Zoccai G; Virmani R;
    JACC Cardiovasc Interv; 2014 Sep; 7(9):958-68. PubMed ID: 25129664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Ariza-Solé A; Sánchez-Elvira G; Sánchez-Salado JC; Lorente-Tordera V; Salazar-Mendiguchía J; Sánchez-Prieto R; Romaguera-Torres R; Ferreiro-Gutiérrez JL; Gómez-Hospital JA; Cequier-Fillat A
    Thromb Res; 2013; 132(6):652-8. PubMed ID: 24112751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of unidirectional flow shear stresses on the formation, fractal microstructure and rigidity of incipient whole blood clots and fibrin gels.
    Badiei N; Sowedan AM; Curtis DJ; Brown MR; Lawrence MJ; Campbell AI; Sabra A; Evans PA; Weisel JW; Chernysh IN; Nagaswami C; Williams PR; Hawkins K
    Clin Hemorheol Microcirc; 2015; 60(4):451-64. PubMed ID: 25624413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of antiplatelet action with high (100 mg) versus standard (60 mg) loading dose of prasugrel in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: pharmacodynamic study.
    Alexopoulos D; Makris G; Xanthopoulou I; Patsilinakos S; Deftereos S; Gkizas V; Perperis A; Karanikas S; Angelidis C; Tsigkas G; Koutsogiannis N; Hahalis G; Davlouros P
    Circ Cardiovasc Interv; 2014 Apr; 7(2):233-9. PubMed ID: 24668226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.